Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia.

Kämpjärvi K, Järvinen TM, Heikkinen T, Ruppert AS, Senter L, Hoag KW, Dufva O, Kontro M, Rassenti L, Hertlein E, Kipps TJ, Porkka K, Byrd JC, de la Chapelle A, Vahteristo P.

Oncotarget. 2015 Jan 30;6(3):1884-8.

2.

Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.

Eisfeld AK, Schwind S, Patel R, Huang X, Santhanam R, Walker CJ, Markowitz J, Hoag KW, Jarvinen TM, Leffel B, Perrotti D, Carson WE 3rd, Marcucci G, Bloomfield CD, de la Chapelle A.

Sci Signal. 2014 Apr 15;7(321):ra36. doi: 10.1126/scisignal.2004762.

3.

Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease.

Hertlein E, Beckwith KA, Lozanski G, Chen TL, Towns WH, Johnson AJ, Lehman A, Ruppert AS, Bolon B, Andritsos L, Lozanski A, Rassenti L, Zhao W, Jarvinen TM, Senter L, Croce CM, Symer DE, de la Chapelle A, Heerema NA, Byrd JC.

PLoS One. 2013 Oct 9;8(10):e76607. doi: 10.1371/journal.pone.0076607. eCollection 2013.

4.

Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations.

Wang C, Ahlford A, Järvinen TM, Nordmark G, Eloranta ML, Gunnarsson I, Svenungsson E, Padyukov L, Sturfelt G, Jönsen A, Bengtsson AA, Truedsson L, Eriksson C, Rantapää-Dahlqvist S, Sjöwall C, Julkunen H, Criswell LA, Graham RR, Behrens TW, Kere J, Rönnblom L, Syvänen AC, Sandling JK.

Eur J Hum Genet. 2013 Sep;21(9):994-9. doi: 10.1038/ejhg.2012.277. Epub 2012 Dec 19.

5.

Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population.

Järvinen TM, Hellquist A, Zucchelli M, Koskenmies S, Panelius J, Hasan T, Julkunen H, D'Amato M, Kere J.

Rheumatology (Oxford). 2012 Jan;51(1):87-92. doi: 10.1093/rheumatology/ker263. Epub 2011 Oct 27. Review.

PMID:
22039224
6.

Genetic background and the risk of otitis media.

Hafrén L, Kentala E, Järvinen TM, Leinonen E, Onkamo P, Kere J, Mattila PS.

Int J Pediatr Otorhinolaryngol. 2012 Jan;76(1):41-4. doi: 10.1016/j.ijporl.2011.09.026. Epub 2011 Oct 21.

PMID:
22018929
7.

Polymorphisms of the ITGAM gene confer higher risk of discoid cutaneous than of systemic lupus erythematosus.

Järvinen TM, Hellquist A, Koskenmies S, Einarsdottir E, Panelius J, Hasan T, Julkunen H, Padyukov L, Kvarnström M, Wahren-Herlenius M, Nyberg F, D'Amato M, Kere J, Saarialho-Kere U.

PLoS One. 2010 Dec 2;5(12):e14212. doi: 10.1371/journal.pone.0014212.

8.

Identification of MAMDC1 as a candidate susceptibility gene for systemic lupus erythematosus (SLE).

Hellquist A, Zucchelli M, Lindgren CM, Saarialho-Kere U, Järvinen TM, Koskenmies S, Julkunen H, Onkamo P, Skoog T, Panelius J, Räisänen-Sokolowski A, Hasan T, Widen E, Gunnarson I, Svenungsson E, Padyukov L, Assadi G, Berglind L, Mäkelä VV, Kivinen K, Wong A, Cunningham Graham DS, Vyse TJ, D'Amato M, Kere J.

PLoS One. 2009 Dec 7;4(12):e8037. doi: 10.1371/journal.pone.0008037.

9.

Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus.

Järvinen TM, Hellquist A, Koskenmies S, Einarsdottir E, Koskinen LL, Jeskanen L, Berglind L, Panelius J, Hasan T, Ranki A, Kere J, Saarialho-Kere U.

Exp Dermatol. 2010 Feb;19(2):123-31. doi: 10.1111/j.1600-0625.2009.00982.x. Epub 2009 Sep 16.

10.

Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.

Hellquist A, Järvinen TM, Koskenmies S, Zucchelli M, Orsmark-Pietras C, Berglind L, Panelius J, Hasan T, Julkunen H, D'Amato M, Saarialho-Kere U, Kere J.

J Rheumatol. 2009 Aug;36(8):1631-8. doi: 10.3899/jrheum.081160. Epub 2009 Jun 30.

PMID:
19567624
11.

Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations.

Koskenmies S, Järvinen TM, Onkamo P, Panelius J, Tuovinen U, Hasan T, Ranki A, Saarialho-Kere U.

Lupus. 2008 Apr;17(4):337-47. doi: 10.1177/0961203307087403.

PMID:
18413417
12.

A population-specific diabetogenic haplotype HLA-A2,Cw1,B56,DR4,DQ8 is associated with high birthweight in Finnish diabetic families.

Järvinen TM, Harjutsalo V, Kinnunen L, Miettinen ME, Tuomilehto-Wolf E, Tuomilehto J.

Genes Immun. 2008 Apr;9(3):207-13. doi: 10.1038/gene.2008.3. Epub 2008 Feb 14.

PMID:
18273034
13.

Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.

Järvinen TM, Kanninen P, Jeskanen L, Koskenmies S, Panelius J, Hasan T, Ranki A, Saarialho-Kere U.

Br J Dermatol. 2007 Nov;157(5):970-80. Epub 2007 Sep 13.

PMID:
17854363
14.

How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population?

Wang JJ, Li HB, Kinnunen L, Hu G, Järvinen TM, Miettinen ME, Yuan S, Tuomilehto J.

Atherosclerosis. 2007 May;192(1):161-8. Epub 2006 May 23.

PMID:
16720024

Supplemental Content

Loading ...
Support Center